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INTRODUCTION
Diabetes mellitus remains as the major global health
problems in most countries even though there are plenty
of antidiabetic agents available in the market. This is due
to side effects produced by some of these agents including
hypoglycaemic coma, hepatorenal disturbances (Suba et
al. 2004) and gastrointestinal adverse reaction (Campbell
2000) Therefore, searching for safer antidiabetic agents
with less side effects should be continued. The uses of
herbal remedies for diabetes treatment are well known since
ancient times.
Ficus deltoidea from Moraceae family is one of the
commonly used medicinal plants in Malaysia (Mat-Salleh
& Latif 2002). Based on ethnobothanical approaches, this
plant has been traditionally claimed to have antidiabetic
property and has been used as traditional remedy for
diabetes treatment. However, scientific evidence to confirm
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ABSTRACT
Ficus deltoidea or Mas cotek is one of the common medicinal plants used in Malaysia has been claimed to have
antidiabetic activity. However, scientific evidence to confirm its efficacy is still lacking. Thus, the present study was
undertaken to evaluate the potential of ethanolic extract of Ficus deltoidea to reduce hyperglycaemia in streptozotocin-
induced diabetic rats at different prandial state. The results showed that, ethanolic extract of Ficus deltoidea significantly
reduced fasting and postprandial hyperglycemia particularly after 4 and 6 hours of extract administration. Likewise,
glucose tolerance activity was significantly improved in the presence of Ficus deltoidea ethanolic extract at a low dose,
100 mg/kg. It is suggested that ethanolic extract of Ficus deltoidea at particular doses, possess fasting and postprandial
antihyperglycemic activity as well as glucose tolerance activity in streptozotocin-induced diabetic rats.
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ABSTRAK
Ficus deltoidea atau Mas Cotek merupakan salah satu tumbuhan ubatan di Malaysia yang dikatakan mempunyai
aktiviti antidiabetik. Walau bagaimanapun, bukti saintifik yang mengesahkan keberkesanannya masih kurang. Kajian
ini bertujuan untuk menilai potensi ekstrak ethanol Ficus deltoidea sebagai agen hipoglisemia pada tikus diabetik
aruhan streptozotocin. Keputusan menunjukkan bahawa ekstrak ethanol Ficus deltoidea secara signifikan
mengurangkan hiperglisemia puasa dan pascaprandial terutama pada 4 dan 6 jam selepas pengambilan ekstrak.
Begitu juga, aktiviti toleransi glukosa telah dipertingkatkan secara signifikan dengan kehadiran ekstrak ethanol
Ficus deltoidea pada dos rendah, 100 mg/kg. Berdasarkan kajian ini, dicadangkan bahawa ekstrak ethanol Ficus
deltoidea pada dos tertentu menunjukkan aktiviti antihiperglisemia puasa dan selepas prandial serta aktiviti toleransi
glukosa pada tikus diabetik aruhan streptozotocin.
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its efficacy is still lacking. Only two studies has been done
which reported the glucose lowering effect of aqueous
extract of F. deltoidea in normal rats (Aminudin et al. 2007)
and mild diabetic rats (Adam et al. 2007). This plant which
is native to Southeast Asia and Philiphines (Forest et al.
2003), also been used to treat other kinds of ailment such
as headache and fever (Mat Salleh & Latif 2002). Recent
studies reported on the antinociceptive activity (Sulaiman
et al. 2008) and antiulcerogenic activity (Siti Fatimah Zahra
et al. 2009) of aqueous extract of F. deltoidea. Hakiman and
Maziah (2009) have found that aqueous extract of different
F. deltoidea accessions possess non enzymatic and
enzymatic antioxidant activities.
The present study was undertaken to evaluate the
potential of ethanolic extract of Ficus deltoidea in reducing
blood glucose level in streptozotocin-induced diabetic rats
at different prandial states.
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MATERIALS AND METHODS
CHEMICALS
Ethanol and diethylether were purchased from Merck,
Germany. Carboxymethylcellulose (CMC), metformin,
streptozotocin and glucose were purchased from Sigma
Chemical Co. (St. Louise, USA).
PLANT MATERIAL AND EXTRACT PREPARATION
F. deltoidea plants were collected at Sungai Tengi Selatan,
Selangor, Malaysia. The specimen was identified by
taxonomist from Biodiversity Unit, Institute of Bioscience,
Universiti Putra Malaysia. A specimen was deposited at
the herbarium of the mentioned institute with voucher
number SK1467/07. The leaves of Ficus deltoidea were dried
at 45°C and ground into a fine powder. Ethanolic extract
was prepared by soaking the sample powder into 70%
ethanol for 3 days (100 g/L) at room temperature by
changing solvent daily. The combined suspension was
filtered through a whatman filter paper No. 54 and
evaporated to dryness under reduced pressure.
EXPERIMENTAL ANIMALS AND DIABETES INDUCTION
Sprague Dawley rats used in the study were breed in house
at Animal House of Malaysian Nuclear Agency. Adult male
rats weighing 200-250 g were used in the study. Animals
were housed in polycarbonate cages and fed on a standard
laboratory pellet diet with water supplied ad libitum. All
animal procedures were approved by Animal Care and Use
Committee (ACUC), Faculty of Medicine and Health Science,
Universiti Putra Malaysia (ACUC no: UPM/FPSK/PADS/BR/
UUH/F01-00208). Diabetes was induced by a single
intravenous (tail vein) injection of streptozotocin (60 mg/
kg; 100 mg/ml in distilled water) under ether anesthesia.
The solution of streptozotocin was freshly prepared, as
the drug is very labile in solution. Fasting blood glucose
was checked 7 days after injection and rats with blood
glucose level more than 13.0 mmol/L were considered
diabetic (Kesari et al. 2006). Diabetic rats were randomly
divided into five groups (seven rats in each group). Group
I (control rats) were given vehicle, 1% carboxymethylcelulose
(CMC). Group II, III and IV were treated with ethanolic
extract of Ficus deltoidea suspended in 1% CMC at doses
of 100, 500 and 1000 mg/kg, respectively. Group V was
treated with metformin at dose of 500 mg/kg.
ANTIHYPERGLYCEMIC TEST IN FASTING AND
POSTPRANDIAL STATE
In fasting state, diabetic rats were fasted 12-hour prior to
test whereas in postprandial state, diabetic rats were fasted
1-hour prior to test. After fasting period, rats were treated
with F. deltoidea ethanolic extracts at different doses
(groups II, III and IV) or metformin (group V) orally using
intragastric gavage. Blood samples were collected before
(0 hour) and after 2, 4 and 6 hour of extracts or metformin
administration for the measurement of blood glucose
concentration.
ORAL GLUCOSE TOLERANCE TEST (OGTT)
Fasting blood glucose was checked in 12 hours fasted
diabetic rats (-30 min) followed by oral administration of F.
deltoidea ethanolic extracts or metformin suspended in
1% CMC orally using intragastric gavage. Thirty minutes
later (at 0 hour), rats of all groups were given glucose (1.5
g/kg; 100 mg/ml in distilled water) orally using intragastric
gavage. Blood samples were collected just prior to glucose
administration (0 min) and 30, 60, 120 and 180 minutes after
glucose administration. Total glyceamic responses to OGTT
were calculated from respective areas under the glucose
curve (AUCGlucose) at the 180 minutes observation period
using a computer calculator software provided by Thomas
Wolever from Department of Nutritional Sciences,
University of Toronto, Toronto, Ontario, Canada (Jalil et al.
2008).
BLOOD COLLECTION AND DETERMINATION
OF GLUCOSE LEVEL
Blood samples were collected from the tip of the rats’ tails
under mild ether anesthesia. The glucose level was
determined using an electronic glucometer, Accu Check
Advantage from Roche Diagnostic (Indianapolis, USA)
(Jayakar & Suresh 2003).
STATISTICAL ANALYSES
All results are expressed as the mean ± standard deviation
for a given number of observations. The data were analyzed
using one way Analysis of Variance (ANOVA), followed by
Tukey’s post hoc test. The group means were considered
significantly different at the level of p < 0.05.
RESULTS
ANTIHYPERGLYCEMIC ACTIVITY OF FICUS DELTOIDEA
Table 1 shows the effect of various doses of ethanolic
extract of F. deltoidea on fasting blood glucose in
streptozotocin-induced diabetic rats. It was shown that
extract at doses of 100 and 500 mg/kg significantly reduced
fasting blood glucose level after 2, 4 and 6 hours of
administration whereas extract at dose of 1000 mg/kg
significantly reduced fasting blood glucose after 4 and 6
hours of administration compared to the 0 hour. Metformin
significantly reduced fasting blood glucose concentration
after 2, 4 and 6 hours of administration.
The effects of various doses of ethanolic extract of F.
deltoidea on postprandial blood glucose in streptozotocin-
induced diabetic rats are shown in Table 2. Extract at dose
of 100 mg/kg significantly reduced postprandial blood
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TABLE 1. Effect of ethanol extract of F. deltoidea on fasting blood glucose level in
streptozotocin-induced diabetic rats
Treatment group Blood glucose level (mmol/L) (mean ± SD)
0 hr 2 hr 4 hr 6 hr
Control 17.97 ± 0.54 18.17 ± 1.17 16.80 ± 1.32 16.23 ± 1.12
F. deltoidea 100 mg/kg/b.w. 16.67 ± 1.44 14.00 ± 0.85 12.93 ± 1.21 12.69 ± 1.26
(16.02)** (22.44)*** (23.88)***
F. deltoidea 500 mg/kg/b.w. 16.91 ± 1.32 12.94 ± 1.64 11.96 ± 1.58 11.96 ± 1.61
(23.48)*** (29.27)*** (29.27)***
F. deltoidea 1000 mg/kg/b.w. 17.90 ± 1.33 15.95 ± 1.61 14.02 c 1.66 13.62 ± 2.66
(21.68)** (23.91)**
Metformin 500 mg/kg/b.w. 16.77 ± 0.72 8.14 ± 3.07 3.19 ± 0.52 3.60 ± 0.96
(51.44)** (81.00)*** (78.53)***
Note: Values in bracket indicate percentage of blood glucose reduction relative to 0-hour of the respective treatment group.
**p < 0.01 and ***p < 0.001 compared to 0 hour of the respective group
glucose after 4 and 6 hours of administration whereas extract
at dose of 1000 mg/kg significantly reduced postprandial
blood glucose level after 2, 4 and 6 hours of administration
compared to the 0 hour. In contrast, extract at dose of 500
mg/kg did not reduce postprandial blood glucose even
though until 6 hours post administration. Metformin
significantly reduced postprandial hyperglycemia after 2,
4 and 6 hours of administration.
ORAL GLUCOSE TOLERANCE TEST
The effects of various doses of ethanolic extract of F.
deltoidea on glucose tolerance activity in streptozotocin-
induced diabetic rats are shown in Table 3. All group of
rats showed almost similar blood glucose level at 0 min.
The highest increase in blood glucose level was observed
30 min after glucose administration in all groups with the
changes of blood glucose level were 1.47-fold, 1.37-fold,
1.46-fold and 1.36-fold and 1.16-fold in control group,
ethanolic extract 100 mg/kg, ethanolic extract 500 mg/kg,
ethanolic extract 1000 mg/kg and metformin group,
respectively compared to glucose administration time (0
min) of respective treatment group. There was no reduction
in blood glucose level in groups treated with ethanolic
extracts (all doses) compared to the respective time of
control group. In contrast, metformin treated group showed
a significant reduction of blood glucose concentration at
30, 60, 120 and 180 minutes after glucose loaded compared
to respective time from control group (Table 3).
Areas under the glucose curve (AUCGlucose) for each
individual rat, calculated to determine the increment of
blood glucose concentration from 0 to 180 minutes is shown
in Table 4. The results showed that, extract at dose of 100
mg/kg significantly attenuated AUCGlucose value by 48.87%
(p<0.05) compared with control group. However, the
attenuation of AUCGlucose value by such extracts was less
than metformin which attenuated AUCGlucose value by 94.78%
(p < 0.001) relative to control group.
DISCUSSION
F. deltoidea has been used for long time as traditional
medicine to counter high blood glucose. However, scientific
studies to evaluate its efficacy and possible mode of action
are still lacking. In the present study, the potential
TABLE 2. Effect of ethanol extract of F. deltoidea on post prandial blood glucose
level in streptozotocin-induced diabetic rats
Treatment group Blood glucose level (mmol/L) (mean ± SD)
0 hr 2 hr 4 hr 6 hr
Control 26.60 ± 2.24 25.05 ± 3.64 22.88 ± 5.13 21.53 ± 3.33
F. deltoidea 100 mg/kg/b.w. 26.17 ± 3.56 22.49 ± 3.23 20.44 ± 3.09 18.80 ± 2.12
(21.90)** (28.16)***
F. deltoidea 500 mg/kg/b.w. 23.8 1 ± 0.98 21.21 ± 2.48 21.29 ± 2.44 21.93 ± 1.21
F. deltoidea 1000 mg/kg/b.w. 23.56 ± 2.18 19.86 ± 1.53 19.62 ± 1.00 20.10 ± 1.58
(15.70)** (16.72)** (14.69)**
Metformin 500 mg/kg/b.w. 27.18 ± 3.78 19.67 ± 3.95 14.57 ± 4.96 13.18 ± 3.72
(27.63)* (46.39)*** (51.57)***
Note: Values in bracket indicate percentage of blood glucose reduction relative to 0-hour of the respective treatment group.
*p < 0.05, **p < 0.01 and ***p < 0.001 compared to 0 hour of the respective group
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TABLE 3. Effect of ethanol extract of F. deltoidea on blood glucose level during oral
glucose tolerance test in streptozotocin-induced diabetic rats
Treatment group Blood glucose level (mmol/L) (mean ± SD)
-30 min 0 min 30 min 60 min 120 min 180 min
Control 17.11 ± 1.95 18.53 ± 1.30 27.33 ± 2.95 24.76 ± 3.50 19.11 ± 3.70 16.93 ± 3.81
F. deltoidea 18.79 ± 2.69 20.72 ± 2.53 28.38 ± 4.05 24.89 ± 2.76 20.13 ± 2.16 17.97 ± 1.82
100 mg/kg/b.w.
F. deltoidea 17.30 ± 2.69 18.95 ± 2.57 27.61 ± 2.77 26.61 ± 3.01 22.53 ± 1.33 17.90 ± 1.87
500 mg/kg/b.w.
F. deltoidea 17.73 ± 1.94 19.63 ± 1.58 26.75 ± 1.92 25.35 ± 3.45 19.60 ± 1.53 15.74 ± 1.75
1000 mg/kg/b.w.
Metformin 17.73 ± 1.72 18.86 ± 2.60 21.87 ± 3.54 19.56 ± 2.60 12.54 ± 3.59 8.92 ± 4.24
500 mg/kg/b.w. (19.98%)** (21.00%)** (34.38%)** (47.31%)**
Note: Values in bracket indicate percentage of blood glucose reduction relative to respective time of control group. **p<0.01 compared with
respective time of control group
antihyperglycemic property of ethanolic extract of F.
deltoidea was evaluated at different prandial state; fasting,
postprandial and glucose loaded state. Antihyperglycemic
test in fasting and postprandial state were performed to
evaluate whether extract has the tendency to counter fasting
and post prandial hyperglycemia respectively. Likewise,
glucose tolerance test was done to evaluate whether the
extract has the potential to improve glucose tolerance
activity. A significant reduction of blood glucose level was
found after supplementation by F. deltoidea ethanolic
extract at the mentioned prandial states, suggesting that
there is possibility of presence of antihyperglycemic
compounds in the studied extract.
In order to challenge the potential of ethanolic extract
of F. deltoidea in reducing blood glucose concentration,
conventional antihyperglycemic agent, metformin was used
as a positive control. Metformin which is belonging to
biguanides group has been reported to be an effective
antihyperglycemic agent with the main mechanism is
through enhancement of glucose uptake into muscle cells
and reduction of hepatic gluconeogenesis, thereby
reducing glucose concentration in blood stream (Chehade
& Mooradian 2000).
TABLE 4. Value of area under glucose curve during oral glucose tolerance test in
the presence of ethanol extract of F. deltoidea
Treatment group AUCGlucose value (mmol/L)
(mean ± SD) 95 % CI (mmol/L) (mean ± SD)
Control 802.50 ± 320.90 404.00 – 1201.00
F. deltoidea 100 mg/kg/b.w. 410.30 ± 119.00 300.20 – 520.30
(48.87)*
F. deltoidea 500 mg/kg/b.w. 635.50 ± 81.64 534.10 – 736.90
F. deltoidea 1000 mg/kg/b.w. 486.00 ± 166.60 346.80 – 625.30
Metformin 500 mg/kg/b.w. 41.88 ± 16.26 21.69 – 62.07
(94.78)***
Note: Values in bracket indicate percentage of AUCGlucose attenuation relative to control group. *p < 0.05 and ***p < 0.001
compared with control group
Although less potent than metformin, ethanolic extract
of F. deltoidea shows the ability to reduce fasting blood
glucose in streptozotocin-induced diabetic rats. However,
this reduction did not reach normoglycemic level even after
6 hours of extract administration. Metformin reduced fasting
blood glucose to less than normoglycemic level 4 hours
after administration. The less potential of fasting
antihyperglycemic activity of ethanolic extract of F.
deltoidea compared to metformin could be due to the
presence of a mixture of bioactive and non-bioactive
compounds in the extracts. This would reduce the
concentration of active compounds in the extract and
decrease the ability of the extracts to reduce fasting blood
glucose. In contrast, metformin consists of single
constituent and its antihyperglycemic activity has been
scientifically proven (Chehade & Mooradian 2000).
Maximum fasting antihyperglycemic activity was shown
by moderate dose of extract, 500 mg/kg after 4 hours of
extract administration followed by the lowest dose, 100
mg/kg and the highest dose, 1000 mg/kg. The latter two
doses, 100 mg/kg and 1000 mg/kg possess similar degree
of post prandial blood glucose reduction after 4 and 6 hours
of extract administration.
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In postprandial antihyperglycemic evaluation, the
lowest dose, 100 mg/kg significantly reduced post prandial
hyperglycemia after 4 hours of administration whereas the
highest dose, 1000 mg/kg starts to reduce hyperglycemia
as early as 2 hours after administration (Table 2). This
observation indicates that the onset of antihyperglycemic
effect by extract at low dose is slower than high dose. This
could be due to the less amount of bioactive constituent(s)
presence in low dose of extract and hence it takes long time
for bioactive constituent(s) in the extract to enter circulation
and reach the target tissue. The highest postprandial
antihyperglycemic activity was shown at dose of 100 mg/
kg and followed by 1000 mg/kg. Unlike such doses, the
moderate dose, 500 mg/kg did not show postprandial
antihyperglycemic activity. In this evaluation, neither
extracts nor did metformin reduced postprandial
hyperglycemia to normoglycemic level even after 6 hours
of administration. There is possibility that, it takes more
than 6 hours for the extracts or metformin to enter circulation
and reach the target tissue and brings the postprandial
antihyperglycemic effect. Of three doses evaluated, the
lowest dose, 100 mg/kg appeared to be the most effective
dose as it caused maximum lowering effect of postprandial
hyperglycemia in streptozotocin-induced diabetic rats.
In oral glucose tolerance study, extract at low dose,
100 mg/kg significantly attenuated AUCGlucose value
compared to the control group. This suggests that such
dose of extract has the ability to improve glucose tolerance
activity in streptozotocin-induced diabetic rats.
Nevertheless, this activity appeared to be less effective as
compared with metformin. The efficiency of metformin in
improving glucose tolerance activity was almost double
from that seen in ethanolic extract 100 mg/kg (Table 4).
This observation indicates that the glucose tolerance
activity shown by such extract was not potent as shown
by metformin. This may be due to the presence of
compounds in F. deltoidea ethanolic extracts which do not
possess glucose tolerance activity. Therefore, to enhance
the effectiveness of such extract in improving glucose
tolerance, further works are needed to be carried out to
isolate the bioactive constituent(s) with glucose tolerance
activity from the extract. Of three doses evaluated, the
lowest dose, 100 mg/kg seem to be most potent in improving
glucose tolerance activity in streptozotocin-induced
diabetic rats. The remaining doses, 500 mg/kg and 1000
mg/kg did not produced expected higher glucose tolerance
activity than 100 mg/kg. This could be due to the presence
of other compounds in higher doses which may antagonist
or interfering the glucose tolerance activity.
Antihyperglycemic plants mediate fasting and
postprandial antihyperglycemic activity through various
mechanisms such as stimulating insulin secretion from
pancreatic beta cells (Gireesh et al. 2009), augmentation of
glucose transport into peripheral cells (Jung et al. 2009;
Anandharajan et al. 2005) and inhibition of α-glucosidase
activity in small intestine (Nickavar et al. 2008). In the present
study, the mechanism by which ethanolic extract of F.
deltoidea mediates antihyperglycemic activity is not
elucidated. There is possibility that ethanolic extract of F.
delttoidea mediates antihyperglycemic activity through the
mentioned mechanisms. However, further evaluations are
needed to be carried out to confirm this suggestion. The
control of postprandial hyperglycemia is one of the
beneficial therapies for management of diabetes mellitus
(Kim et al. 2005) along with medical nutrition therapy, oral
hypoglycaemic agents and insulin therapy (David 2005).
Therefore, the uses of plants with postprandial
antihyperglycemic property such as Mucuna pruriens
(Anusha et al. 2008) and Cynara cardunculus (Nomikos et
al. 2007) as well as plants with glucose tolerance property
such as Helicteres ixora (Venkatesh et al. 2004) and
Tournefortia hartwegiana (Ortiz-andrade et al. 2007) may
benefits the diabetes patients in controlling postprandial
hyperglycemia. Based on the results of the present study,
it is suggested that Ficus deltoidea may advantageous
the diabetes patients in the management of postprandial
hyperglycemia as well as diabetes mellitus.
This study had shown that ethanolic extract of Ficus
deltoidea possess fasting and postprandial
antihyperglycemic activity as well as glucose tolerance
activity in streptozotocin-induced diabetic rats. Therefore,
it is suggested that Ficus deltoidea could be used as dietary
adjunct to counter hyperglycemia in diabetes patients and
has the potential to be developed as new oral
antihyperglycemic agent for the treatment of diabetes
mellitus.
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